Dose-escalating Safety and Preliminary Efficacy of DaxibotulinumtoxinA for Injection in Cervical Dystonia
Clinical trial NCT02706795 · COMPLETED
Trial details
- NCT number
- NCT02706795
- Sponsor
- Revance Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-12-07
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.